Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-040411
Filing Date
2022-02-14
Accepted
2022-02-14 11:17:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d312547dsc13g.htm SC 13G 37482
  Complete submission text file 0001193125-22-040411.txt   39159
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39444 | Film No.: 22627242
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

EIN.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G